INVO Fertility (IVF) Research & Development (2020 - 2025)

INVO Fertility has disclosed Research & Development across 6 years of filings, most recently posting $127807.0 for Q2 2025.

• Quarterly Research & Development changed N/A year-over-year to $127807.0 in Q2 2025, while the trailing twelve-month figure through Sep 2025 was $777120.0 (up 7104.23% YoY) and the FY2024 annual result came in at $388530.0, up 134.13% from the prior year.
• Research & Development slipped to $127807.0 in Q2 2025, from $265663.0 in the prior quarter.
• Across five years, Research & Development topped out at $383650.0 in Q4 2024 and bottomed at $2668.0 in Q3 2023.
• The 5-year median for Research & Development is $73677.5 (2022), against an average of $106776.1.
• Year-over-year, Research & Development slumped 98.48% in 2023 and jumped 6394.84% in 2024.
• INVO Fertility's Research & Development stood at $63756.0 in 2021, then gained by 15.81% to $73835.0 in 2022, then tumbled by 92.0% to $5907.0 in 2023, then jumped by 6394.84% to $383650.0 in 2024, then slumped by 66.69% to $127807.0 in 2025.
• According to Business Quant data, Research & Development over the past three periods registered $127807.0, $265663.0, and $383650.0 for Q2 2025, Q1 2025, and Q4 2024 respectively.